The Sidney Kimmel Comprehensive Cancer Center at John Hopkins

Baltimore, Maryland 21231

We've found

4 trials

at this facility

Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Baltimore, MD

Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Baltimore, MD

Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Baltimore, MD

Dose-escalation Study of Birinapant and Pembrolizumab in Solid Tumors

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!